Target Name: TECTA
NCBI ID: G7007
Review Report on TECTA Target / Biomarker Content of Review Report on TECTA Target / Biomarker
TECTA
Other Name(s): tectorin alpha | DFNA12 | Alpha-tectorin | TECTA_HUMAN | DFNA8 | DFNB21 | Tectorin alpha

TECTA: A Protein with Potential Applications

Tectinin alpha, also known as TECTA, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the tetraspanin family, which are a group of four transmembrane proteins that play a fundamental role in cell-cell signaling.

One of the unique features of TECTA is its ability to interact with several different proteins, including the protein involved in the development and maintenance of blood vessels, called PDGF. This interaction between TECTA and PDGF has led to the potential use of TECTA as a drug target or biomarker for various diseases.

In addition to its role in cell-cell signaling, TECTA has also been shown to play a key role in several cellular processes that are important for maintaining tissue health and homeostasis. For example, TECTA has been shown to regulate the production of pro-inflammatory cytokines, which can contribute to the development of chronic inflammatory diseases such as heart disease and diabetes.

Another important function of TECTA is its role in the regulation of cell division and growth. TECTA has been shown to interact with the protein p16INK4a, which plays a key role in regulating the growth and division of cancer cells. This interaction between TECTA and p16INK4a has led to the potential use of TECTA as a drug target or biomarker for various cancers.

In addition to its potential use as a drug target or biomarker, TECTA has also been shown to have potential therapeutic applications in a variety of other fields. For example, TECTA has been shown to have anti-inflammatory effects, which could make it a useful treatment for a variety of inflammatory diseases.

In addition, TECTA has also been shown to have potential applications in the field of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. The anti-inflammatory effects of TECTA make it a potential treatment for these diseases, as the build-up of inflammation in these diseases is thought to contribute to the development and progression of these diseases.

Overall, TECTA is a protein that has a wide range of potential applications in a variety of fields. Its ability to interact with multiple proteins and its role in several cellular processes make it an attractive target for drug development or biomarker research. Further studies are needed to fully understand the functions of TECTA and its potential as a drug or biomarker.

Protein Name: Tectorin Alpha

Functions: One of the major non-collagenous components of the tectorial membrane (By similarity). The tectorial membrane is an extracellular matrix of the inner ear that covers the neuroepithelium of the cochlea and contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals

The "TECTA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TECTA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TECTB | TEDC1 | TEDC2 | TEDC2-AS1 | TEDDM1 | TEF | TEFM | TEK | TEKT1 | TEKT2 | TEKT3 | TEKT4 | TEKT4P1 | TEKT4P2 | TEKT5 | TEKTIP1 | TELO2 | Telomerase holoenzyme complex | TEN1 | TEN1-CDK3 | Teneurin | TENM1 | TENM2 | TENM2-AS1 | TENM3 | TENM3-AS1 | TENM4 | TENT2 | TENT4A | TENT4B | TENT5A | TENT5B | TENT5C | TENT5C-DT | TENT5D | TEP1 | TEPP | TEPSIN | TERB1 | TERB2 | TERC | TERF1 | TERF1P3 | TERF2 | TERF2IP | TERLR1 | TERT | TES | TESC | TESK1 | TESK2 | TESMIN | TESPA1 | TET1 | TET2 | TET2-AS1 | TET3 | Tetraspanin | TEX10 | TEX101 | TEX11 | TEX12 | TEX13A | TEX13B | TEX13C | TEX14 | TEX15 | TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1